Cardioprotective effects of pinacidil pretreatment and lazaroid (U74500A) preservation in isolated rat hearts after 12-hour hypothermic storage

Transplantation

Volumn 66, Issue 2, 1998, Pages 158-163

  Du, Zu Y ^a   Hicks, Mark ^a   Spratt, Phillip ^a   Mundy, Julie A ^a   Macdonald, Peter S ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

21 [4 [5,6 BIS(DIETHYLAMINO) 2 PYRIDYL] 1 PIPERAZINYL] 16ALPHA METHYLPREGNA 1,4,9(11) TRIENE 3,20 DIONE; ADENOSINE TRIPHOSPHATE; CARDIOPLEGIC AGENT; LAZAROID; PINACIDIL; POTASSIUM CHANNEL; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA FLOW; ARTICLE; CARDIOPLEGIA; CORONARY ARTERY BLOOD FLOW; HEART FUNCTION; HEART OUTPUT; HEART PRESERVATION; HEART PROTECTION; HYPOTHERMIA; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; COLD; GUANIDINES; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; MALE; ORGAN PRESERVATION; PINACIDIL; POTASSIUM CHANNELS; PREGNATRIENES; RATS; RATS, WISTAR;

EID: 0032558164     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199807270-00003     Document Type: Article

References (37)

1. Stringham JC, Southard JH, Hegge J, Triemstra L, Fields BL, Beizer FO. Limitations of heart preservation by cold storage. Transplantation 1992; 53: 287.
2. Garlick PB, Davies MJ, Hearse DJ, Slater TF. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 1987; 61: 757.
3. Fishbein MC. Reperfusion injury. Clin Cardiol 1990; 13: 213.
4. Southard JH, Beizer FO. Organ preservation. Annu Rev Med 1995; 46: 235.
5. Pflugfelder PW, Thompson D, Singh NR, Menkis AH, McKenzie FN, Kostuk WJ. Cardiac allograft ischemic time: relation to graft survival and cardiac function. Circulation 1989; 80 (suppl III): III-116.
6. Stringham JC, Southard JH, Hegge J, Triemstra L, Fields BL, Belzer FO. Limitations of heart preservation by cold storage. Transplantation 1992; 53: 287.
7. Young JB, Naftel DC, Bourge RC, et al. Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group. J Heart Lung Transplant 1994; 13: 353.
8. Weston AH, Edwards G. Recent progress in potassium channel opener pharmacology. Biochem Pharmacol 1994; 43: 47.
9. Grover GJ. The role of ATP-sensitive potassium channels in myocardial ischemia: pharmacology and implications for the future. In: Karmazyn M, ed. Myocardial ischemia: mechanisms, reperfusion, protection. Basel: Birkhäuser Verlag, 1996: 313.
10. Hearse DJ. Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection? Cardiovasc Res 1995; 30: 1.
11. ATP channels. [Abstract]. J Heart Lung Transplant 1997; 16(1): 39.
12. Villa RF, Gorini A. Pharmacology of lazaroids and brain energy metabolism: a review. Pharmacol Rev 1997; 49: 99.
13. Nashida T, Morita S, Miyamoto K, et al. Lazaroid (U74500A) prevents vascular and myocardial dysfunction after 24-hour heart preservation: a study based on cross-circulated bloodperfused rabbit hearts. Circulation 1996; 94(suppl II): II-326.
14. Tanoue Y, Morita S, Ochiai Y, et al. Inhibition of lipid peroxidation with the lazaroid U74500A attenuates ischemia-reperfusion injury in a canine orthoptic heart transplantation model. J Thorac Cardiovasc Surg 1996; 112: 1017.
15. Du Z, Hicks M, Winlaw D, Macdonald P, Spratt P. Lazaroid U74500A enhances donor lung preservation in the rat transplant model. Transplant Proc 1995; 27: 3574.
16. Du ZY, Hicks M, Spratt P, Macdonald P. Enhanced preservation of the rat heart after hypothermic storage with the 21-aminosteroid compound U74500A. Asia Pacific Heart J 1997; 6: 184.
17. Choong YS, Gavin JB. Functional, metabolic and ultrastructural evidence for improved myocardial protection during severe ischaemic stress with MBS, a new cardioplegic solution. J Cardiovasc Surg 1996; 37: 275.
18. Saldahna C, Hearse DJ. Coronary vascular responsiveness to 5-hydroxytryptamine before and after infusion of hyperkalemic crystalloid cardioplegic solution in rat heart: possible evidence for endothelial damage. J Thorac Cardiovasc Surg 1989; 98: 783.
19. Nilsson FN, Miller VM, Vanhoutte PM, McGregor CG. Methods of cardiac preservation alter the function of porcine coronary arteries. J Thorac Cardiovasc Surg 1991; 102: 923.
20. Cartier R, Dagenais F, Hollman C, Carrier M, Pelletier LC. The role of preservation solutions in coronary endothelial damage during cold storage. Transplantation 1993; 56: 997.
21. Killinger WA, Dorfi DB, Keagy BA, Johnson G. Improvement of endothelial cell viability at 4°C by addition of lazaroid U74500A to preservation solutions. Transplantation 1992; 53: 983.
22. Perna AM, Liguori P, Bonacchi M, et al. Protection of the rat heart from ischaemia-reperfusion injury by the 21-aminosteroid U74389G. Pharmacol Res 1996; 34: 25.
23. Stewart JR, Gerhardt EB, Wehr CJ, et al. Free radical scavengers and myocardial protection during transplantation. Ann Thorac Surg 1986; 42: 390.
24. Opie LH. Role of calcium and other ions in reperfusion injury. Cardiovasc Drugs Ther 1991; 5(suppl 2): 237.
25. Knight RJ, Dikman S, Liu H, Martinelli GP. Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model. Transplantation 1997; 64: 1102.
26. Menasche P. New strategies in myocardial preservation. Curr Opin Cardiol 1997; 12: 504.
27. Lopez JR, Jahangir R, Jahangir A, Shen WK, Terzic A. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia. J Thorac Cardiovasc Surg 1996; 112: 820.
28. Davies MG, Dalen H, Barber L, Svendsen E, Hagen P-O. Lazaroid therapy (U83836E) reduces vein graft intimai hyperplasia. J Surg Res 1996; 63: 128.
29. Rangan U, Bulkley GB. Prospects for the treatment of free radical-mediated tissue injury. Br Med Bull 1993; 49: 700.
30. Xia Y, Zwier JL. Substrate control of free radical generation in the postischemic heart. J Biol Chem 1995; 270: 18739.
31. + channels involves high energy phosphate preservation. Am J Physiol 1993; 265: H1809.
32. Damiano RJ. The electrophysiology of ischemia and cardioplegia: implications for myocardial protection. J Card Surg 1995; 10: 445.
33. Sanders SA, Eisenthal R, Harrison R. NADH oxidase activity of xanthine oxido-reductase: generation of superoxide anion. Eur J Biochem 1997; 245: 541.
34. + channel openers protect hippocampal neurons against oxidative injury and amyloid beta-peptide activity. Brain Res 1996; 706: 328.
35. Hall ED, McCall JM. Antioxidant actions of lazaroids. Methods Enzymol 1994; 234: 548.
36. Audus KL, Guillot FL, Braughler JM. Evidence for 21-aminosteroid association with the hydrophobic domain of brain microvessel endothelial cells. Free Radic Biol Med 1991; 11: 361.
37. Wang Y, Mathews WR, Guido DM, Jaeschke H. The 21-aminosteroid tirilazad mesylate protects against liver injury via membrane stabilization not inhibition of lipid peroxidation. J Pharmacol Exp Ther 1996; 277: 714.